Mayfair Capital has agreed to sell the Hinshelwood Building, located at the Oxford Science Park, in a £19.5m deal.
The 2.1-acre site was sold to TOSP, which is majority owned by Magdalen College.
The 31,567 sq ft building contains offices over two floors, a central atrium and a 150 car-parking spaces.
The building is currently vacant and was bought with the view for a potential conversion into research and development facility as it incorporates “spots” that allow the creation of laboratory space.
The move comes as TOSP has plans to create more than 500,000 sq ft of additional office and laboratory space over the next three years alongside its strategic partner GIC.
The park already serves as a home to Blue Earth Diagnostics, MiroBio, OrganOx, OxSonics Therapeutics, Oxford Nanopore Technologies, OXGENE, ProImmune, Oxford Science Enterprises, Evox Therapeutics, Exscientia and Intuitive Surgical.
Rory Maw, chief executive of TOSP, said: “Taking control of the building enhances our ability to provide a balance of flexible office and laboratory space to our fast-growing base of occupiers as well as new companies moving to the park.”
Cushman & Wakefield and Bryan Cave Leighton Paisner acted for TOSP.
To send feedback, e-mail evelina.grecenko@eg.co.uk or tweet @Gre_Eve or @EGPropertyNews
See which agents are doing the most deals in Oxfordshire >>
